INBX earnings: next report 2026-08-12, real EPS beat/miss history, analyst consensus Buy, P/E -10.24. Updated 2026-07-23.
Inhibrx Biosciences (INBX) Research Hub
Inhibrx Biosciences (INBX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 109.27 USD (-3.18%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.24, market cap 1.27B. This hub links to the full technical, earnings and options research available for INBX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 109.27 USD (-3.18%) |
| 52-week range | 77.51 USD – 131.01 USD |
| Trend regime | Range |
| 14-day RSI | 65.8 (Bullish) |
| Trailing P/E | -10.24 |
| Market cap | 1.27B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for INBX
Covered Call on INBX: how it works, illustrative setup around the real 109.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on INBX: how it works, illustrative setup around the real 109.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on INBX: how it works, illustrative setup around the real 109.27 USD price, max profit/loss, breakeven and when to use it. Educational.
INBX technical analysis: range, last 109.27 USD, RSI 65.8, 52w range 77.51 USD–131.01 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is INBX in?
Inhibrx Biosciences (INBX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is INBX in an uptrend or downtrend?
As of 2026-09-11, INBX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is INBX's trailing P/E ratio?
INBX's trailing P/E is -10.24, with a market cap of 1.27B. See the earnings research page for full valuation detail.
When does INBX next report earnings?
INBX is next scheduled to report earnings on 2026-08-12, with a consensus EPS estimate of -2.28 USD.